Replies to post #136874 on Biotech Values

[zipjet]

I've wondered for a while why A*'s (in)ability to pay for even 1x damages wasn't a part of the MNTA/NVS argument for irreparable harm.

I suspect it is because of the perception that Watson (shall I call them joint tortfeasor) could respond in damages. The Texaco situation supports the argument that might not be true.